The energy pattern of 10 different Coxsackie strains.

10 vials. 

Coxsackie A2

Coxsackie A3

Coxsackie A4

Coxsackie A5

Coxsackie A7

Coxsackie B1

Coxsackie B3

Coxsackie B4

Coxsackie B5

Coxsackie B6

In general, group A coxsackieviruses tend to infect the skin and mucous membranes, causing herpangina; acute haemorrhagic conjunctivitis; and hand, foot, and mouth (HFM) disease.

Group B coxsackieviruses tend to infect the heart, pleura, pancreas, and liver, causing pleurodynia, myocarditis, pericarditis, and hepatitis (inflammation of the liver not related to the hepatotropic viruses). Coxsackie B infection of the heart can lead to pericardial effusion.

Both group A and group B coxsackieviruses can cause nonspecific febrile illnesses, rashes, upper respiratory tract disease, and aseptic meningitis.

The development of insulin-dependent diabetes (IDDM) has recently been associated with recent enteroviral infection, particularly coxsackievirus B pancreatitis. This relationship is currently being studied further.

Sjögren syndrome is also being studied in connection with coxsackievirus.

Life-Work Potential product code: 8145

Note: Ergopathics test kits are not intended to diagnose, prevent, treat or cure any disease, disorder or abnormal physical state. The vials contain ethanol and water and the process used to imprint them with electromagnetic signatures has not been tested or validated by any scientific method and is not approved by any regulatory authority. They are intended for use solely by qualified providers to support wellness and manage stress. Vials do not contain any substances classified as a DINs of NHPs by Health Canada.